ScholarIQanswers from OpenAlex

Analysis of the common genetic component of large-vessel vasculitides through a meta-Immunochip strategy

PaperCitations, authors & open-access status

Analysis of the common genetic component of large-vessel vasculitides through a meta-Immunochip strategy is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Analysis of the common genetic component of large-vessel vasculitides through a meta-Immunochip strategy have?

ScholarIQcitation count

Analysis of the common genetic component of large-vessel vasculitides through a meta-Immunochip strategy has 72 citations in the OpenAlex counts ScholarIQ stores.

When was Analysis of the common genetic component of large-vessel vasculitides through a meta-Immunochip strategy published?

ScholarIQyear

Analysis of the common genetic component of large-vessel vasculitides through a meta-Immunochip strategy has 2017 year in the ScholarIQ index.

What is the open-access status of Analysis of the common genetic component of large-vessel vasculitides through a meta-Immunochip strategy?

ScholarIQoa status

Analysis of the common genetic component of large-vessel vasculitides through a meta-Immunochip strategy has gold oa status in the ScholarIQ index.

What is the DOI of Analysis of the common genetic component of large-vessel vasculitides through a meta-Immunochip strategy?

ScholarIQdoi

The DOI for Analysis of the common genetic component of large-vessel vasculitides through a meta-Immunochip strategy is on the source record.

What is the PMID of Analysis of the common genetic component of large-vessel vasculitides through a meta-Immunochip strategy?

ScholarIQpmid

The PMID for Analysis of the common genetic component of large-vessel vasculitides through a meta-Immunochip strategy is on the source record.

What is the OpenAlex record for Analysis of the common genetic component of large-vessel vasculitides through a meta-Immunochip strategy?

ScholarIQopenalex

The OpenAlex for Analysis of the common genetic component of large-vessel vasculitides through a meta-Immunochip strategy is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial